Euroapi S.A. (EPA:EAPI)

France flag France · Delayed Price · Currency is EUR
2.940
+0.066 (2.30%)
Jul 23, 2025, 5:35 PM CET
2.30%
Market Cap273.69M
Revenue (ttm)919.20M
Net Income (ttm)-130.60M
Shares Out95.23M
EPS (ttm)-1.38
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume67,561
Average Volume107,043
Open2.886
Previous Close2.874
Day's Range2.886 - 2.948
52-Week Range2.260 - 4.540
Beta0.68
RSI38.80
Earnings DateJul 29, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances.... [Read more]

Sector Healthcare
Founded 2020
Employees 3,187
Stock Exchange Euronext Paris
Ticker Symbol EAPI
Full Company Profile

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial Statements